<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00707044</url>
  </required_header>
  <id_info>
    <org_study_id>MEC 01-039</org_study_id>
    <secondary_id>00106 (CVZ)</secondary_id>
    <nct_id>NCT00707044</nct_id>
  </id_info>
  <brief_title>Short-Stay Intensive Care for Coronary Artery Bypass Patients</brief_title>
  <official_title>Short-Stay Intensive Care for Coronary Artery Bypass Patients,Development of a Guideline for Giving Adequate Care on the Cardiosurgical Intensive Care</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Dutch Health Care Insurance Board (nr: 00106), Amstelveen, The Netherlands</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Maastricht University Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objective: To evaluate the safety and cost-effectiveness of Short Stay Intensive Care (SSIC)
      treatment for low-risk coronary artery bypass patients Design: Randomized clinical
      equivalence trial Setting: University Hospital Maastricht, the Netherlands Patients: low-risk
      coronary artery bypass patients Interventions: 600 patients were randomly assigned to undergo
      either SSIC treatment (8 hours Intensive Care) or control treatment (care as usual, overnight
      Intensive Care).

      Measurements: The primary outcome measures were Intensive Care (IC) readmissions and total
      hospital stay. The secondary outcome measures were total hospital costs, Quality of Life
      (QoL), postoperative morbidity and mortality. Hospital costs consisted of the cost of
      hospital admission(s) and outpatient costs.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2001</start_date>
  <completion_date type="Actual">May 2004</completion_date>
  <primary_completion_date type="Actual">October 2003</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intensive Care (IC) readmissions</measure>
    <time_frame>one month postoperative</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>total hospital stay, total hospital costs, postoperative morbidity and mortality</measure>
    <time_frame>one month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>generic and disease specific Quality of Life (QoL)</measure>
    <time_frame>one year postoperative</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">597</enrollment>
  <condition>Coronary Artery Bypass</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Short-Stay Intensive Care treatment (SSIC), 8 hours of Intensive care treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>control group, care as usual, 24 hours intensive care stay</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Control group (usual care)</intervention_name>
    <description>control group, care as usual, 24 hours intensive care stay</description>
    <arm_group_label>B</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Short-Stay Intensive Care treatment (SSIC)</intervention_name>
    <description>Short-Stay Intensive Care treatment (SSIC), 8 hours of Intensive care treatment</description>
    <arm_group_label>A</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Coronary artery bypass patients

        Exclusion Criteria:

          -  age older than 78 years,

          -  ejection fraction of less than 30%

          -  stage 3 obesity (BMI&gt;40kg/m2)

          -  haemodialysis (kidney replacing therapy)

          -  pulmonary hypertension (systolic &lt;40mmHg)

          -  recent CVA (&lt;1month)

          -  recent myocardial infarction (&lt;24hours)

          -  cardiogenic shock, (systolic blood pressure&lt;80mmHg,

          -  central filling pressure&gt;20mmHg,

          -  cardiac index&lt;1.8 litres/minute/m2),

          -  need for inotropic therapy (&gt;5mg/mcg/min. dopamine or dobutamine)

          -  ongoing infarction (a significant increase of enzyme &quot;CKMB&quot; within 4 hours before
             surgery)

          -  the need for intra-aortic balloon pump

          -  inability to give informed consent

          -  inability to speak/ read/ understand the Dutch language

          -  patients who had emergency surgery.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>78 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ghislaine van Mastrigt, Msc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maastricht University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Maastricht</name>
      <address>
        <city>Maastricht</city>
        <zip>6202AZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <results_reference>
    <citation>van Mastrigt GA, Heijmans J, Severens JL, Fransen EJ, Roekaerts P, Voss G, Maessen JG. Short-stay intensive care after coronary artery bypass surgery: randomized clinical trial on safety and cost-effectiveness. Crit Care Med. 2006 Jan;34(1):65-75.</citation>
    <PMID>16374158</PMID>
  </results_reference>
  <verification_date>June 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 26, 2008</study_first_submitted>
  <study_first_submitted_qc>June 27, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 30, 2008</study_first_posted>
  <last_update_submitted>February 22, 2017</last_update_submitted>
  <last_update_submitted_qc>February 22, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">February 24, 2017</last_update_posted>
  <responsible_party>
    <name_title>Mr. M. van Essen</name_title>
    <organization>Dutch Health Care Insurance Board</organization>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

